题名

Peptic Ulcer Disease and Its Association with Metabolic Syndrome among Medical-checkup Subjects from One Teaching Hospital in Taiwan

并列篇名

台灣某教學醫院健檢受檢者之代謝症候群與消化性潰瘍之相關性

DOI

10.3966/168232812019032901003

作者

沈容宇(Jung-Yu Shen)；吳美鳳(Mei-Fong Wu)；張玉君(Yu-Jun Chang)；楊佩玉(Pei-Yu Yang)；林益卿(I-Ching Lin)

关键词

metabolic syndrome ； obesity ； peptic ulcer disease ； 消化性潰瘍 ； 肥胖 ； 代謝症候群

期刊名称

台灣家庭醫學雜誌

卷期/出版年月

29卷1期（2019 / 03 / 01）

页次

23 - 33

内容语文

英文
中文摘要

Purpose: Previous studies have indicated that a high body mass index is a risk factor for asymptomatic peptic ulcer disease. A high body mass index is also the main risk factor for metabolic syndrome. This study aimed to evaluate the association between peptic ulcer disease and metabolic syndrome. Methods: This was a cross-sectional study conducted at one teaching hospital in midland of Taiwan, from January 2013 to December 2014. We reviewed the medical-checkup result of participants who visited the Health Examination Center of the hospital. We included 4,895 participants who received upper gastrointestinal endoscopy. Results: The mean age of the 4,895 participants was 50.01 ± 11.2 years. In simple logistic regression analysis, peptic ulcer disease was related to age (odds ratio [OR] 1.99, 95% CI 1.60-2.48), male sex (OR 1.76, 95% CI 1.50-2.07), increased abdominal circumference (OR 1.43, 95% CI 1.22-1.67), increased triglycerides (OR 1.21, 95% CI 1.03-1.43), elevated blood pressure (BP) (OR 1.80, 95% CI 1.54-2.09), elevated fasting blood glucose (OR 1.45, 95% CI 1.24-1.69) and metabolic syndrome (OR 1.56, 95% CI 1.33-1.82). In multiple regression analysis, peptic ulcer disease was related to male sex (OR 1.51, 95% CI 1.27-1.79), smoking (OR 1.46, 95% CI 1.19-1.78), increased abdominal circumference (OR 1.22, 95% CI 1.03-1.44) and elevated BP (OR 1.46, 95% CI 1.24-1.73). After adjusting for age, sex and smoking, peptic ulcer disease was still associated with metabolic syndrome (OR 1.39, 95% CI 1.19-1.64). Conclusion: Metabolic syndrome is associated with peptic ulcer disease. Lifestyle modifications and treating metabolic syndrome may prevent peptic ulcer disease.
英文摘要

目的：在亞洲（包括台灣），消化性潰瘍的盛行率有越來越多的趨勢。過去的研究顯示高身體質量指數是無症狀消化性潰瘍的危險因子之一。且高身體質量指數是代謝症候群的主要危險因子。然而很少研究討論消化性潰瘍和代謝症候群的相關性。本篇研究是評估消化性潰瘍和代謝症候群之間的相關性。方法：這篇是從2013年至2014年的橫斷式研究，總共4,895位受試者，匯集其基本資料（年齡、身高、體重、身體質量指數、腹圍、病史及生活習慣），並在台灣中部一所教學醫院的健檢中心接受身體理學檢查、抽血檢驗和胃鏡檢查。代謝症候群的定義是根據台灣衛生署國民健康局的診斷標準。結果：4,895位受試者，平均年齡為50.01±11.2歲，消化性潰瘍和代謝症候群的盛行率分別為16.8％和28.5％。在簡單邏輯斯迴歸分析（simple logistic regression model），消化性潰瘍和年齡（odds ratio〔OR〕1.99，95％CI 1.60－2.48），男性（OR 1.76，95％CI 1.50－2.07），腹部肥胖（OR 1.43，95％CI 1.22－1.67），高三酸甘油酯（OR 1.21，95％CI 1.03－1.43），高血壓（OR 1.80，95％ CI 1.54－2.09），高飯前血糖（OR 1.45，95％CI 1.24－1.69）相關。代謝症候群和消化性潰瘍有相關性（OR 1.56，95％CI 1.33－1.82）。在多元迴歸分析（multiple regression model），消化性潰瘍和男性（OR 1.51，95％CI 1.27－1.79），腹部肥胖（OR 1.22，95％CI 1.03－1.44），高血壓（OR 1.46，95％CI 1.24－1.73）相關。如控制年齡性別與吸菸，消化性潰瘍和代謝症候群有顯著相關（OR 1.39，95％CI 1.19－1.64）。結論：這個研究顯示代謝症候群和消化性潰瘍具有相關性。年齡、男性、腹部肥胖、高三酸甘油酯、高血壓、高飯前血糖都與消化性潰瘍相關。因此，對有代謝症候群的族群可加強生活型態的改善，以期避免消化性潰瘍的發生。
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Aydemir, S,Bayraktaroglu, T,Sert, M(2005).The effect of Helicobacter pylori on insulin resistance.Dig Dis Sci,50,2090-2093.
  2. Barak, N,Ehrenpreis, ED,Harrison, JR,Sitrin, MD(2002).Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations.Obes Rev,3,9-15.
  3. Blaser, MJ,Chyou, PH,Nomura, A(1995).Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk.Cancer Res,55,562-565.
  4. Boylan, MR,Khalili, H,Huang, ES,Chan, AT(2014).Measures of adiposity are associated with increased risk of peptic ulcer.Clin Gastroenterol Hepatol,12,1688-1694.
  5. Cheng, TJ,Guo, HR,Chang, CY(2016).The Association Between Peptic Ulcer Disease and Ischemic Stroke: A Population-Based Longitudinal Study.Medicine,95,e3797.
  6. Ding, S,Chi, MM,Scull, BP(2010).High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.PLoS One,5,e12191.
  7. Dixon, JB,O'Brien, PE(2006).Obesity and the white blood cell count: changes with sustained weight loss.Obes Surg,16,251-257.
  8. Eckel, RH,Alberti, K,Grundy, SM,Zimmet, PZ(2010).The metabolic syndrome.Lancet,375,181-183.
  9. Haj, S,Chodick, G,Refaeli, R,Goren, S,Shalev, V,Muhsen, K(2017).Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study.PLoS One,12,e0183687.
  10. Jones, MP(2006).The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs.J Psychosom Res,60,407-412.
  11. Kim, J,Kim, KH,Lee, BJ(2017).Association of peptic ulcer disease with obesity, nutritional components, and blood parameters in the Korean population.PLoS One,12,e0183777.
  12. Kurata, JH,Nogawa, AN(1997).Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.J Clin Gastroenterol,24,2-17.
  13. Lanas, A,Chan, FK(2017).Peptic ulcer disease.Lancet,390,613-624.
  14. Ley, RE(2010).Obesity and the human microbiome.Curr Opin Gastroenterol,26,5-11.
  15. Nomura, A,Stemmermann, GN,Chyou, PH,Perez-Perez, GI,Blaser, MJ(1994).Helicobacter pylori infection and the risk for duodenal and gastric ulceration.Ann Intern Med,120,977-981.
  16. O'Neill, S,O'Driscoll, L(2015).Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.Obes Rev,16,1-12.
  17. Snowden, FM(2008).Emerging and reemerging diseases: a historical perspective.Immunol Rev,225,9-26.
  18. Sonnenberg, A(1988).Concordant occurrence of gastric and hypertensive diseases.Gastroenterol,95,42-48.
  19. Sonnenberg, A,Everhart, JE(1996).The prevalence of self-reported peptic ulcer in the United States.Am J Public Health,86,200-205.
  20. Stemmermann, G,Haenszel, W,Locke, F(1977).Epidemiologic pathology of gastric ulcer and gastric carcinoma among Japanese in Hawaii.J Natl Cancer Inst,58,13-20.
  21. Taylor, DN,Blaser, MJ(1991).The epidemiology of Helicobacter pylori infection.Epidemiol Rev,13,42-59.
  22. Tilg, H,Moschen, AR,Kaser, A(2009).Obesity and the microbiota.Gastroenterol,136,1476-1483.
  23. Tsai, WL,Yang, CY,Lin, SF,Fang, FM(2004).Impact of obesity on medical problems and quality of life in Taiwan.Am J Epidemiol,160,557-565.
  24. Wang, FW,Tu, MS,Mar, GY(2011).Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan.World J Gastroenterol,17,1199-1203.
  25. Wisen, O,Rossner, S,Johansson, C(1987).Gastric secretion in massive obesity. Evidence for abnormal response to vagal stimulation.Dig Dis Sci,32,968-972.
  26. Xia, B,Xia, HH,Ma, CW(2005).Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.Aliment Pharmacol Ther,22,243-249.
  27. Yeh, CJ,Chang, HY,Pan, WH(2011).Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008.Asia Pac J Clin Nutr,20,292-300.
  28. Yoshitoshi, Yed.(1971)。Ulcer of the Stomach and Duodenum。Tokyo:Nankodo。
  29. 衛生福利部國民健康署：成人代謝症候群之判斷標準（2007台灣）。2007年05月01日，修改2018年06月12日，取自https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=639&pid=1219
print cancel